Nontuberculous Mycobacterial Lung Disease Overview

Save information for later
Sign Up

Learn About Nontuberculous Mycobacterial Lung Disease

What is the definition of Nontuberculous Mycobacterial Lung Disease?
Nontuberculous mycobacterial lung disease is a non-contagious, non-tuberculosis infection caused by bacteria commonly found in water and soil. The disease can also affect other areas of the body, such as the skin, bones, and lymph nodes. Nontuberculous mycobacterial lung disease more commonly affects people with compromised immune systems and pre-existing lung disease, such as chronic obstructive pulmonary disease and cystic fibrosis.
What are the symptoms of Nontuberculous Mycobacterial Lung Disease?
A person infected with nontuberculous mycobacterial lung disease may have no symptoms or only mild symptoms. Other symptoms of nontuberculous mycobacterial lung disease may include shortness of breath, chronic cough, coughing up sputum, coughing up blood, wheezing, chest pain, recurrent respiratory infections, anxiety, weakness, fatigue, fever, rashes, swollen lymph nodes, night sweats, loss of appetite, diarrhea, and unexplained weight loss.
Not sure about your diagnosis?
Check Your Symptoms
What are the current treatments for Nontuberculous Mycobacterial Lung Disease?
Treatment for nontuberculous mycobacterial lung disease may include watchful waiting; respiratory therapy, such as nebulizers, to clear airways; amikacin liposome inhalation suspension; antiviral medications; and antibiotics. In rare instances, surgery may be needed to remove an infected portion of the lung.
Who are the top Nontuberculous Mycobacterial Lung Disease Local Doctors?
Kevin L. Winthrop
Elite in Nontuberculous Mycobacterial Lung Disease
Dr. Kevin L. Winthrop
Infectious Disease
Elite in Nontuberculous Mycobacterial Lung Disease
Dr. Kevin L. Winthrop
Infectious Disease

University Professional Services

3181 Sw Sam Jackson Park Rd, 
Portland, OR 
503-494-8311
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Kevin Winthrop is an Infectious Disease provider in Portland, Oregon. Dr. Winthrop is rated as an Elite provider by MediFind in the treatment of Nontuberculous Mycobacterial Lung Disease. His top areas of expertise are Mycobacterium Avium Complex Infections, Shingles, Nontuberculous Mycobacterial Lung Disease, Cataract Removal, and Hip Replacement. Dr. Winthrop is currently accepting new patients.

Timothy R. Aksamit
Elite in Nontuberculous Mycobacterial Lung Disease
Dr. Timothy R. Aksamit
Pulmonary Medicine
Elite in Nontuberculous Mycobacterial Lung Disease
Dr. Timothy R. Aksamit
Pulmonary Medicine

Mayo Clinic Health System-Southeast Minnesota Region

2250 Nw 26th St, 
Owatonna, MN 
507-451-3850
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Timothy Aksamit is a Pulmonary Medicine provider in Owatonna, Minnesota. Dr. Aksamit is rated as an Elite provider by MediFind in the treatment of Nontuberculous Mycobacterial Lung Disease. His top areas of expertise are Bronchiectasis, Nontuberculous Mycobacterial Lung Disease, Mycobacterium Avium Complex Infections, and Lung Metastases. Dr. Aksamit is currently accepting new patients.

 
 
 
 
Learn about our expert tiers
Learn More
Elite in Nontuberculous Mycobacterial Lung Disease
Dr. David E. Griffith
Infectious Disease | Pulmonary Medicine
Elite in Nontuberculous Mycobacterial Lung Disease
Dr. David E. Griffith
Infectious Disease | Pulmonary Medicine

National Jewish Health

1400 Jackson St, 
Denver, CO 
303-398-1355
Languages Spoken:
English
See accepted insurances
Accepting New Patients

David Griffith is an Infectious Disease specialist and a Pulmonary Medicine provider in Denver, Colorado. Dr. Griffith is rated as an Elite provider by MediFind in the treatment of Nontuberculous Mycobacterial Lung Disease. His top areas of expertise are Mycobacterium Avium Complex Infections, Nontuberculous Mycobacterial Lung Disease, Bronchiectasis, and Lung Metastases. Dr. Griffith is currently accepting new patients.

View All Doctors
What are the latest Nontuberculous Mycobacterial Lung Disease Clinical Trials?
A Single-Center Observational Biomarker Investigation of Response to Bacteriophage Treatment for Bacterial Infection
A Single-Center Observational Biomarker Investigation of Response to Bacteriophage Treatment for Bacterial Infection
Enrollment Status: Recruiting
Publish Date: October 30, 2025
Intervention Type: Biological

Summary: This study aims to identify biomarkers associated with response to phage therapy for refractory bacterial infections. This includes mycobacteriophage treatment for patients with nontuberculous mycobacterial infections. Blood and airway samples will be obtained from follow up visits of patients with refractory bacterial infections that are considered for phage therapy. Samples will be compared betw...

Match to trials
Find the right clinical trials for you in under a minute
Get started
Hypertonic Saline for Treatment of Pulmonary Mycobacterium Avium Complex (MAC) Disease
Hypertonic Saline for Treatment of Pulmonary Mycobacterium Avium Complex (MAC) Disease
Who is this study for: Adult patients with Mycobacterial Lung Disease
Enrollment Status: Recruiting
Publish Date: August 15, 2025
Intervention Type: Drug
Study Drugs: Azithromycin, Ethambutol, Rifampin, Hypertonic Saline
Study Phase: Phase 4

Summary: The MAC-HS study is a testing whether hypertonic saline helps improve symptoms and clearance of mycobacteria in patients with M. avium complex lung infections.

View All Clinical Trials